Skip to content

Other financials

Income statement

See full
Revenue$71.4M-7.5%
Gross profit$21.2M-11.6%
Operating income$5.2M-38.6%
Net income$3.4M-30.1%
EPS (diluted)$1.13-30.7%

Balance sheet

See full
Cash & equivalents$10.0M-42.0%
Total debt$25.3M+6.6%
Total equity$74.7M+15.9%
Total assets$178.3M-8.4%

Cash flow

See full
Operating cash flow$5.5M-42.0%
CapEx$928.0K+79.8%
Free cash flow$4.5M-49.0%

Valuation

See full
Market cap$101.96M-34.8%
Enterprise value$117.3M-28.0%
P/E10.6×-3.1×
P/S0.4×-0.3×

Profitability

See full
Gross margin28.5%-0.1pp
Operating margin5.9%-1.5pp
Net margin3.4%-1.3pp
FCF margin5.2%

Returns & leverage

See full
Return on equity13.8%-5.3pp
Debt / equity0.3×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by Kewaunee Scientific Corporation in its filing.

Tagged under the XBRL concept kequ:ShortTermBorrowingsAndInterestRateSwap.

The official record: Kewaunee Scientific Corporation’s 10-Q, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kewaunee Scientific Corporation's short-term borrowings.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kewaunee Scientific Corporation's short-term borrowings?
Kewaunee Scientific Corporation (KEQU) reported short-term borrowings of $1.54M in Q4 2025.
How has Kewaunee Scientific Corporation's short-term borrowings changed year-over-year?
Kewaunee Scientific Corporation's short-term borrowings increased by 36.3% year-over-year, from $1.13M to $1.54M.
What is the long-term trend for Kewaunee Scientific Corporation's short-term borrowings?
Over 4 years (2021 to 2025), Kewaunee Scientific Corporation's short-term borrowings has grown at a -38.4% compound annual growth rate (CAGR), from $6.83M to $986K.